X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+21.3%
5Y CAGR+22.4%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+21.3%/yr
vs +96.7%/yr prior
5Y CAGR
+22.4%/yr
Consistent
Acceleration
-75.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.7x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $217.05M | +289.7% |
| 2024 | $55.70M | -43.9% |
| 2023 | $99.22M | -18.5% |
| 2022 | $121.72M | +48.8% |
| 2021 | $81.79M | +3.6% |
| 2020 | $78.97M | -37.4% |
| 2019 | $126.18M | +1451.3% |
| 2018 | $8.13M | -89.4% |
| 2017 | $76.79M | +2430.2% |
| 2016 | $3.04M | - |